Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center ExperienceJenna Rossoff, William J. Muller, Sonali Chaudhury et al.|Open Forum Infectious Diseases|2019Cited by 131
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Rawan Faramand, Liora M. Schultz et al.|Blood Advances|2025Cited by 15
Reduced‐toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high‐risk hematologic malignanciesJenna Rossoff, Sonali Chaudhury, David A. Jacobsohn et al.|Pediatric Blood & Cancer|2021Cited by 6
Reduced Toxicity, Myeloablative Conditioning Regimen with Busulfan, Fludarabine, Anti-Thymocyte Globulin and 400 Cgy TBI in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant for High-Risk Hematologic MalignanciesJenna Rossoff, Sonali Chaudhury, David A. Jacobsohn et al.|Transplantation and Cellular Therapy|2020Cited by 0
HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALLKevin O. McNerney, Liora M. Schultz, Michael R. Verneris et al.|Blood Advances|2026Cited by 0